Quantbot Technologies LP Sells 92,918 Shares of Oscar Health, Inc. $OSCR

Key Points

• Quantbot Technologies LP significantly reduced its stake in Oscar Health, Inc. by 68.7% in the first quarter, selling 92,918 shares and now holding 42,344 shares worth $555,000.
• Multiple institutional investors, including Larson Financial Group and Caitong International Asset Management, increased their positions in Oscar Health, reflecting a mixed sentiment among hedge funds.
• Analysts have downgraded Oscar Health's stock ratings, with a consensus price target now at $12.07, indicating a “Strong Sell” sentiment from the market.

Quantbot Technologies LP trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 68.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,344 shares of the company's stock after selling 92,918 shares during the quarter. Quantbot Technologies LP's holdings in Oscar Health were worth $555,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in OSCR. Deerfield Management Company L.P. Series C lifted its stake in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the period. Nuveen LLC acquired a new position in Oscar Health during the 1st quarter worth approximately $29,684,000. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Man Group plc raised its stake in Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after buying an additional 1,405,554 shares during the period. Finally, Ancient Art L.P. raised its stake in Oscar Health by 66.8% during the 4th quarter. Ancient Art L.P. now owns 2,950,753 shares of the company's stock worth $39,658,000 after buying an additional 1,182,134 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of research reports. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their price target for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Robert W. Baird reaffirmed a "neutral" rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Barclays dropped their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 23rd. Finally, Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Four investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company's stock. According to MarketBeat.com, Oscar Health has a consensus rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Stock Up 1.3%

Shares of Oscar Health stock traded up $0.22 on Thursday, hitting $17.24. The company had a trading volume of 9,268,723 shares, compared to its average volume of 19,108,916. The stock has a market capitalization of $4.46 billion, a price-to-earnings ratio of -21.28 and a beta of 1.86. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The stock has a 50 day moving average of $16.11 and a 200-day moving average of $14.86. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.Oscar Health's quarterly revenue was up 29.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.20 earnings per share. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.